Search Results
10
Everything
Search Filters
Organization
Purdue Research Foundation
Eradivir announces Phase 2 human challenge study of EV25 in healthy adults infected with influenza
March 10, 2025 08:01 ET
|
Purdue Research Foundation
WEST LAFAYETTE, Ind., March 10, 2025 (GLOBE NEWSWIRE) -- Eradivir, a clinical-stage small molecule immunotherapy biotech company, announced it has begun a Phase 2 challenge study with its antiviral...
High-tech startup CrySyst provides quality-by-control solutions for pharmaceutical, fine chemical industries
March 03, 2025 08:15 ET
|
Purdue Research Foundation
WEST LAFAYETTE, Ind., March 03, 2025 (GLOBE NEWSWIRE) -- International process systems and operation experts have launched high-tech startup Crystallization Systems Technology Inc. (CrySyst) to...
Amplified Sciences earns CLIA certification for its first test to assess pancreatic cancer risk
February 19, 2025 09:01 ET
|
Purdue Research Foundation
WEST LAFAYETTE, Ind., Feb. 19, 2025 (GLOBE NEWSWIRE) -- Amplified Sciences, a clinical-stage life sciences diagnostic company that develops tests for early, more accurate detection of challenging...
Emboa Medical creates, validates novel catheter to improve stroke patients’ outcomes
February 18, 2025 09:01 ET
|
Purdue Research Foundation
WEST LAFAYETTE, Ind., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Emboa Medical Inc., a medical device startup, has mimicked a snake’s evolutionary advantage to improve the retrieval of blood clots that cause...
Eradivir’s EV25 therapeutic proven to reduce advanced-stage influenza viral loads faster, more thoroughly in preclinical studies than current therapies
November 21, 2024 09:24 ET
|
Purdue Research Foundation
WEST LAFAYETTE, Ind., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Eradivir, a preclinical biotech company that licenses innovations from Purdue Research Foundation, has developed a patent-pending antiviral...
Purdue innovations detect lead exposure faster, easier and with greater precision at the point of care
October 31, 2024 09:57 ET
|
Purdue Research Foundation
WEST LAFAYETTE, Ind., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Exposure to lead can adversely impact people’s health in several ways. A Purdue University researcher in the College of Health and Human...
Biotech company Eradivir closes $10.25M Series A funding round to complete Phase 2a study of influenza therapeutic
September 25, 2024 10:00 ET
|
Purdue Research Foundation
WEST LAFAYETTE, Ind., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Eradivir, a preclinical biotech company that develops antiviral therapeutics, has completed a $10.25 million Series A funding round. The...
Biotech company Eradivir is developing lead drug EV25 to treat influenza
July 09, 2024 14:24 ET
|
Purdue Research Foundation
WEST LAFAYETTE, Ind., July 09, 2024 (GLOBE NEWSWIRE) -- Eradivir, a preclinical biotech company, leverages small molecule targeting technology developed in Philip Low’s lab at Purdue University to...
From eureka moments to industry impact: Tillmann Kubis’ quantum code library
July 08, 2024 10:59 ET
|
Purdue Research Foundation
WEST LAFAYETTE, IND., July 08, 2024 (GLOBE NEWSWIRE) -- You could talk to Tillmann Kubis for hours. His laid-back demeanor and desire for everyone to understand what he’s working on is so...
‘Like a hand fitting into a glove’: Purdue-engineered compound designed to treat drug-resistant acute myeloid leukemia
June 20, 2024 10:55 ET
|
Purdue Research Foundation
WEST LAFAYETTE, Ind., June 20, 2024 (GLOBE NEWSWIRE) -- Researchers at Purdue University’s College of Science have developed a patent-pending compound called HSN748 to treat drug-resistant acute...